- Home
- CZNC vs STRO Comparison
CZNC vs STRO Comparison
Compare CZNC & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CZNC
- STRO
- Stock Information
- Founded
- CZNC 1864
- STRO 2003
- Country
- CZNC United States
- STRO United States
- Employees
- CZNC N/A
- STRO N/A
- Industry
- CZNC Major Banks
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CZNC Finance
- STRO Health Care
- Exchange
- CZNC Nasdaq
- STRO Nasdaq
- Market Cap
- CZNC 315.7M
- STRO 172.8M
- IPO Year
- CZNC N/A
- STRO 2018
- Fundamental
- Price
- CZNC $18.53
- STRO $1.90
- Analyst Decision
- CZNC
- STRO Strong Buy
- Analyst Count
- CZNC 0
- STRO 7
- Target Price
- CZNC N/A
- STRO $12.14
- AVG Volume (30 Days)
- CZNC 33.9K
- STRO 1.4M
- Earning Date
- CZNC 10-17-2024
- STRO 11-13-2024
- Dividend Yield
- CZNC 6.02%
- STRO N/A
- EPS Growth
- CZNC N/A
- STRO N/A
- EPS
- CZNC 1.44
- STRO N/A
- Revenue
- CZNC $101,899,000.00
- STRO $160,955,000.00
- Revenue This Year
- CZNC N/A
- STRO N/A
- Revenue Next Year
- CZNC $7.24
- STRO N/A
- P/E Ratio
- CZNC $12.96
- STRO N/A
- Revenue Growth
- CZNC N/A
- STRO 230.90
- 52 Week Low
- CZNC $16.50
- STRO $1.70
- 52 Week High
- CZNC $23.50
- STRO $6.13
- Technical
- Relative Strength Index (RSI)
- CZNC 32.04
- STRO 28.52
- Support Level
- CZNC $18.33
- STRO $1.70
- Resistance Level
- CZNC $19.92
- STRO $1.93
- Average True Range (ATR)
- CZNC 0.51
- STRO 0.20
- MACD
- CZNC -0.19
- STRO -0.01
- Stochastic Oscillator
- CZNC 8.02
- STRO 12.60
About CZNC Citizens & Northern Corp
Citizens & Northern Corp is a community bank operating through its subsidiaries. It provides banking services, including deposit and loan products for personal and commercial customers. The bank also maintains a trust division that provides a wide range of financial services, such as 401(k) plans, retirement planning, estate planning, estate settlements and asset management.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.